Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01960816 · ClinicalTrials.gov registry record · NA

InFlux System for Nasal Breathing Improvement

A NA study of Nasal Airway Obstruction, sponsored by Aerin Medical.

Completed
Registry status
NA
Development phase
33
Enrollment target
2
Study locations

NCT01960816 is a NA study of Nasal Airway Obstruction that has completed, run by Aerin Medical. The registered enrollment target is 33 participants, below the 181-participant average among 3 other Nasal Airway Obstruction trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01960816, a NA study of Nasal Airway Obstruction, has completed, sponsored by Aerin Medical.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
2
Study locations

Study Summary

Pilot Study of the Aerin Medical Wand used for Improvement in Nasal Breathing

Conditions Studied

Interventions

  • DEVICE Procedure: thermal coagulation of tissue in the nasal airway

Study Locations (2)

Massachusetts

  • St. Elizabeth's Medical Center - Boston

Mississippi

  • Bay Area ENT - Ocean Springs

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2013-09
Est. Completion 2016-04
Phase NA

Sponsor

Aerin Medical

14 total trials

What the Registry Record Tells You About NCT01960816

The ClinicalTrials.gov registry entry for NCT01960816 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 181-participant average among 3 other Nasal Airway Obstruction trials with a reported enrollment target (82% lower). The listed sponsor is Aerin Medical, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nasal Airway Obstruction appearing as the primary indexed condition, and to 1 intervention - of which Procedure: thermal coagulation of tissue in the nasal airway is the first listed.

NCT01960816 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Mississippi.

Frequently Asked Questions

What is clinical trial NCT01960816 about?

NCT01960816 is a clinical study titled "InFlux System for Nasal Breathing Improvement". Pilot Study of the Aerin Medical Wand used for Improvement in Nasal Breathing

What is the current status of trial NCT01960816?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2013-09. Estimated completion is 2016-04.

What conditions does trial NCT01960816 study?

This clinical trial studies the following conditions: Nasal Airway Obstruction.

What interventions are being tested in trial NCT01960816?

The interventions under investigation include: Procedure: thermal coagulation of tissue in the nasal airway (DEVICE).

Who is sponsoring clinical trial NCT01960816?

This trial is sponsored by Aerin Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01960816 being conducted?

This trial has 2 study locations across Massachusetts, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nasal Airway Obstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.